Company advancing development of lead program, iTOL-101, as a potential breakthrough in curing Type 1 Diabetes with the potential to eliminate the need for chronic life-long immunosuppression
The up to $850,000 award issued to iTolerance was given in furtherance of JDRF's charitable mission to cure and mitigate the effects of Type 1 Diabetes
MIAMI, FL / ACCESSWIRE / June 28, 2022 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the need for life-long immunosuppression, today announced it has been awarded an Industry Discovery and Development Partnership ("IDDP") of up to $850,000 from JDRF, a nonprofit organization that funds Type 1 Diabetes (T1D) research, provides a broad array of community and activist services to the T1D population and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities.
iTolerance, Inc., Tuesday, June 28, 2022, Press release picture
Anthony Japour, MD, Chief Executive Officer of iTolerance, commented, "We are incredibly pleased to expand and deepen our partnership with the JDRF. We are grateful for their continued support and dedication to the Type 1 Diabetes community. This funding provides us with the additional capital to support the translation of iTOL-100 production, iTolerance's proprietary biotechnology-derived fusion protein immunomodulator platform, from the academic research laboratories to commercial manufacturing. In addition, the partnership will support Good Laboratory Practice efficacy, safety, toxicology, and pharmacokinetic studies. This will put us a step closer toward a first in human Phase 1/2a clinical trial."
Dr. Japour continued, "The support that the JDRF has provided to our team thus far has been significantly valuable in enabling us to complete our pre-clinical non-human primate study which demonstrated long-term success of allogeneic islet implantation without chronic immunosuppression for the treatment of diabetes. The results from that landmark study were recently published[1] in the peer-reviewed journal, Science Advances. We believe the extension of their support with this IDDP is truly a natural next step as we collectively advance towards a potential breakthrough cure for T1D without the need for chronic immunosuppression."
Story continues
The JDRF award to iTolerance is in support of advancing the Company's platform technology, iTOL-100, which leverages the naturally occurring protein, Fas Ligand (FasL) which is present in all mammals and functions as a natural way for the body to establish local immune tolerance. In pre-clinical studies conducted to date, iTOL-100 has been shown to establish durable, localized immune tolerance, allowing the implanted tissue, organoid or cell therapy to function as a replacement for damaged native cells. Additionally, the award supports the advancement of pre-clinical studies evaluating iTolerance's lead program, iTOL-101, to support a first-in-human clinical study in Type 1 Diabetes.
"We enthusiastically support the iTolerance team's effort toward translating to the clinic the work of our JDRF-funded researchers. The recently published study demonstrates long-term glycemic control in a non-human primate model of diabetes by combining allogenic islets with the SA-FasL microgel. This work has the promise to provide a cell replacement therapy that cures T1D without the need for chronic immunosuppression. The advancement of pre-clinical development builds on the ongoing support from JDRF and we look forward to this next stage of development," added Esther Latres, Ph.D., JDRF Vice President of Research.
About JDRF
JDRF's mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).
About iTOL-100
The Company's iTOL-100 platform technology is a biotechnology-derived Strepavidin-FasL fusion protein, a synthetic form of the naturally occurring protein FasL, mixed with a biotin-PEG microgel (SA-FasL microgel) that potentially allows convenient and effective co-administration with implanted cells or organoids to induce local immune tolerance without the need for life-long immunosuppression. In pre-clinical studies, iTOL-100 has been shown to establish durable, localized immune tolerance, allowing the implanted tissue, organoid or cell therapy to function as a replacement for damaged native cells. iTOL-100 has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases.
About iTolerance, Inc.
iTolerance is an early-stage privately held regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the need for life-long immunosuppression. Leveraging its proprietary biotechnology-derived Strepavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic pancreatic islets and stem cells that have the potential to cure diseases. The Company's lead program, iTOL-101 is being developed for Type 1 Diabetes and in a pre-clinical non-human primate study, pancreatic islet cells co-implanted with iTOL-101 exhibited long-term function with control of blood glucose levels and restoration of insulin secretion without the use of chronic immune suppression. The Company's second lead candidate, iTOL-102, is leveraging significant advancements in stem cells to derive pancreatic islets which allows an inexhaustible supply of insulin-producing cells. Utilizing iTOL-100 to induce local immune tolerance, iTOL-102 has the potential to be a cure for Type 1 Diabetes without the need for life-long immunosuppression. Additionally, the Company is developing iTOL-201 for liver failure and iTOL-301 as a potential regenerative protein and cell therapy that leverages stem cell sources to produce proteins or hormones in the body in conditions of high unmet need without the need for life-long immunosuppression. For more information, please visit itolerance.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. When used herein, words such as "anticipate", "being", "will", "plan", "may", "continue", and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking.
All forward-looking statements are based upon the Company's current expectations and various assumptions. The Company believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. The Company may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important factors, including, without limitation, anticipated levels of revenues, future national or regional economic and competitive conditions, and difficulties in developing the Company's platform technology. Consequently, forward-looking statements should be regarded solely as the Company's current plans, estimates and beliefs. Investors should not place undue reliance on forward-looking statements. The Company cannot guarantee future results, events, levels of activity, performance or achievements. The Company does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by law.
[1] https://www.science.org/doi/abs/10.1126/sciadv.abm9881
Investor Contact:
Jenene Thomas Chief Executive Officer JTC Team, LLC T: 833.475.8247 iTolerance@jtcir.com
SOURCE: iTolerance, Inc.
View source version on accesswire.com: https://www.accesswire.com/706772/iTolerance-Inc-Awarded-Industry-Discovery-and-Development-Partnership-with-JDRF-for-Advanced-Pre-Clinical-Development-of-iTOL-100-and-iTOL-101-for-the-Treatment-of-Type-1-Diabetes
The rest is here:
iTolerance, Inc. Awarded Industry Discovery and Development Partnership with JDRF for Advanced Pre-Clinical Development of iTOL-100 and iTOL-101 for...
- Spotlight on Cancer Stem Cell Research – Stem Cell Cafe [Last Updated On: May 22nd, 2011] [Originally Added On: May 22nd, 2011]
- Stem Cells and Controversy – Stem Cell Cafe [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- Lisa Ray asks you to join Stem Cell City – Stem Cell Cafe [Last Updated On: June 28th, 2011] [Originally Added On: June 28th, 2011]
- Michael Savage...Embryonic Stell Cell Research...Part 2 [Last Updated On: August 4th, 2011] [Originally Added On: August 4th, 2011]
- Michael Savage...Embryonic Stell Cell Research...Part 3 [Last Updated On: August 6th, 2011] [Originally Added On: August 6th, 2011]
- Stem Cell Therapy at City of Hope: Building on the Promise [Last Updated On: August 8th, 2011] [Originally Added On: August 8th, 2011]
- Obama on Embryonic Stem Cell Research [Last Updated On: August 9th, 2011] [Originally Added On: August 9th, 2011]
- Medical Treatment by Stem Cells Myth or Reality? Episode 2 - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- Stem Cells Regenerate New Finger! - Video [Last Updated On: October 17th, 2011] [Originally Added On: October 17th, 2011]
- MS Patient After Stem Cell Therapy - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- Stem Cell Transplant - Video [Last Updated On: October 19th, 2011] [Originally Added On: October 19th, 2011]
- The EU and stem cell research - Video [Last Updated On: October 20th, 2011] [Originally Added On: October 20th, 2011]
- Dr. Oz to Oprah and Michael J Fox: "The stem cell debate is dead." - Video [Last Updated On: December 8th, 2011] [Originally Added On: December 8th, 2011]
- Politics: President Obama on Stem Cell Research - Video [Last Updated On: December 9th, 2011] [Originally Added On: December 9th, 2011]
- Be still my beating stem cell heart - Video [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- Adult Stem Cell vs Embryonic Stem Cell Research Ethics Video - Video [Last Updated On: December 19th, 2011] [Originally Added On: December 19th, 2011]
- A new hair loss treatment using stem cells ethically, safely and effectively. - Video [Last Updated On: December 31st, 2011] [Originally Added On: December 31st, 2011]
- U-M Would Have To Report Data On Stell Cell Research In New House Bill [Last Updated On: March 30th, 2012] [Originally Added On: March 30th, 2012]
- Stem Cells Restore Man's Vision | The art of cord blood banking [Last Updated On: January 4th, 2013] [Originally Added On: January 4th, 2013]
- Cancer Stem Cells – Video – Stem Cell Cafe [Last Updated On: January 7th, 2013] [Originally Added On: January 7th, 2013]
- Research and Markets: Stem Cell Therapy Market in Asia-Pacific to ... [Last Updated On: January 13th, 2013] [Originally Added On: January 13th, 2013]
- Genea Stem Cells (GSC): 25 new disease specific pluripotent stem ... [Last Updated On: January 14th, 2013] [Originally Added On: January 14th, 2013]
- Court lifts cloud over embryonic stem cells – Stem Cell Cafe [Last Updated On: January 16th, 2013] [Originally Added On: January 16th, 2013]
- Drug targets leukemia stem cells – Stem Cell Cafe [Last Updated On: January 18th, 2013] [Originally Added On: January 18th, 2013]
- CRF to sponsor 8th International Conference on ... - Stem Cell Cafe [Last Updated On: January 19th, 2013] [Originally Added On: January 19th, 2013]
- Bacteria Can Morph Host Cells Into Stem Cells – Stem Cell Cafe [Last Updated On: January 21st, 2013] [Originally Added On: January 21st, 2013]
- Springhill Medical Group-What is Stem Cell Therapy? - Stem Cell Cafe [Last Updated On: January 22nd, 2013] [Originally Added On: January 22nd, 2013]
- Stem Cells – A Medical Dictionary, Bibliography, And Annotated ... [Last Updated On: January 23rd, 2013] [Originally Added On: January 23rd, 2013]
- StemCells, Inc. to Present at Phacilitate Cell ... - Stem Cell Cafe [Last Updated On: January 24th, 2013] [Originally Added On: January 24th, 2013]
- Stem cells aid recovery from stroke – Stem Cell Cafe [Last Updated On: January 28th, 2013] [Originally Added On: January 28th, 2013]
- Adult Stem Cells Regrow cut off Finger! – Video – Stem Cell Cafe [Last Updated On: February 4th, 2013] [Originally Added On: February 4th, 2013]
- Stem cells is no hype but it is a better hope: Experts – Stem Cell Cafe [Last Updated On: February 6th, 2013] [Originally Added On: February 6th, 2013]
- 3D printing with stem cells could lead to printable organs – Stem ... [Last Updated On: February 6th, 2013] [Originally Added On: February 6th, 2013]
- Monell scientists identify taste stem cells on the tongue – Stem Cell ... [Last Updated On: February 7th, 2013] [Originally Added On: February 7th, 2013]
- Scientists Say 3D Printing Can Create Stem Cells – Video – Stem ... [Last Updated On: February 7th, 2013] [Originally Added On: February 7th, 2013]
- Fish stem cells could light the way to optical breakthroughs – Stem ... [Last Updated On: February 17th, 2013] [Originally Added On: February 17th, 2013]
- Signaling factors may be key to stem cells' healing abilities ... [Last Updated On: February 18th, 2013] [Originally Added On: February 18th, 2013]
- Regenerative medicine and Stem cells Partnering Terms and ... [Last Updated On: February 19th, 2013] [Originally Added On: February 19th, 2013]
- Market Research Report — Therapeutic ... - Stem Cell Cafe [Last Updated On: February 22nd, 2013] [Originally Added On: February 22nd, 2013]
- Cell therapy: New mouse model promises to advance research on ... [Last Updated On: February 22nd, 2013] [Originally Added On: February 22nd, 2013]
- Florida Hospital Pepin Heart Institute, USF partner ... - Stem Cell Cafe [Last Updated On: February 23rd, 2013] [Originally Added On: February 23rd, 2013]
- Schistosome stem cells could explain how the worms survive for so ... [Last Updated On: February 24th, 2013] [Originally Added On: February 24th, 2013]
- Egg cells from Stell Cells: A breakthrough in fertility research | Bionic ... [Last Updated On: February 26th, 2013] [Originally Added On: February 26th, 2013]
- BioMarin Licenses Factor VIII Gene Therapy ... - Stem Cell Cafe [Last Updated On: February 26th, 2013] [Originally Added On: February 26th, 2013]
- 'Holy Grail' of stem cell research discovered – Stem Cell Clinic ... [Last Updated On: March 1st, 2013] [Originally Added On: March 1st, 2013]
- OHSU Doernbecher Scientists First To Grow Liver Stem Cells In ... [Last Updated On: March 1st, 2013] [Originally Added On: March 1st, 2013]
- FRC's Dr. David Prentice Congratulates Kansas ... - Stem Cell Cafe [Last Updated On: March 5th, 2013] [Originally Added On: March 5th, 2013]
- UCLA researchers explore cutting edge of stem cells – Stem Cell Cafe [Last Updated On: March 10th, 2013] [Originally Added On: March 10th, 2013]
- Study finds stem cells in deer antler – Stem Cell Cafe [Last Updated On: March 21st, 2013] [Originally Added On: March 21st, 2013]
- IDIBELL signs agreement with Histocell to use ... - Stem Cell Cafe [Last Updated On: March 29th, 2013] [Originally Added On: March 29th, 2013]
- Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research ... [Last Updated On: March 31st, 2013] [Originally Added On: March 31st, 2013]
- Researchers first to use common virus to 'fortify' adult stem cells ... [Last Updated On: April 2nd, 2013] [Originally Added On: April 2nd, 2013]
- Stem Cells Harvested From Human Gut For First Time - Stem Cell Cafe [Last Updated On: April 6th, 2013] [Originally Added On: April 6th, 2013]
- "Nanokicking" Stem Cells Offers Cheaper And Easier Way To Grow ... [Last Updated On: April 7th, 2013] [Originally Added On: April 7th, 2013]
- Adhesive force differences enable separation of stem cells to ... [Last Updated On: April 8th, 2013] [Originally Added On: April 8th, 2013]
- Embryonic-like stem cells collected from adults to grow bone – Stem ... [Last Updated On: April 8th, 2013] [Originally Added On: April 8th, 2013]
- Pro-lifers eye Kansas for top study of stem cells; no embryo use at ... [Last Updated On: April 12th, 2013] [Originally Added On: April 12th, 2013]
- StemCells, Inc. Enters Agreement to Receive $19.3 ... - Stem Cell Cafe [Last Updated On: April 12th, 2013] [Originally Added On: April 12th, 2013]
- 'Smart' stem cells repair damage from heart failure – Stem Cell Cafe [Last Updated On: April 12th, 2013] [Originally Added On: April 12th, 2013]
- First-in-humans study introduces next generation ... - Stem Cell Cafe [Last Updated On: April 13th, 2013] [Originally Added On: April 13th, 2013]
- Stem Cells Show Promise in Heart Failure Patients – Stem Cell Cafe [Last Updated On: April 15th, 2013] [Originally Added On: April 15th, 2013]
- IDIBELL signs agreement with Histocell to use … – Stem Cell Cafe ... [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Circuit Court OKs Funding of Embryonic Stem Cell Research ... [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Pros And Cons Of Stem Cell Research [Last Updated On: April 16th, 2013] [Originally Added On: April 16th, 2013]
- Adult stem cells offer ethical, effective cures, speakers say ... - First [Last Updated On: April 17th, 2013] [Originally Added On: April 17th, 2013]
- Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged ... [Last Updated On: April 17th, 2013] [Originally Added On: April 17th, 2013]
- Voices Against Brain Cancer Comments on New Study Claiming Fat ... [Last Updated On: April 20th, 2013] [Originally Added On: April 20th, 2013]
- UCLA Researchers Develop New Method for Purifying Stem Cells ... [Last Updated On: April 23rd, 2013] [Originally Added On: April 23rd, 2013]
- Scientist identifies protein molecule used to ... - Stem Cell Cafe [Last Updated On: April 25th, 2013] [Originally Added On: April 25th, 2013]
- Human Stem Cells Injected In Mice Restore Memory, Learning ... [Last Updated On: April 25th, 2013] [Originally Added On: April 25th, 2013]
- Explore the Forefront of iPS Cell Research ... - Stem Cell Cafe [Last Updated On: April 26th, 2013] [Originally Added On: April 26th, 2013]
- Stem Cell Therapy Market in Asia-Pacific to 2018 ... [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- Dr. Farshid Guilak: Can stem cells help those with arthritis? – Stem ... [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- AKC Canine Health Foundation Releases Webinar ... - Stem Cell Cafe [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- German stem cells give new life to cancer patient in Gujarat – Stem ... [Last Updated On: April 29th, 2013] [Originally Added On: April 29th, 2013]
- Stem Cell Therapy Market in Asia-Pacific to 2018 ... - Stem Cell Cafe [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Study confirms that mesenchymal stem cells may help treat cancer ... [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Adults lack stem cells for making new eggs, research shows – Stem ... [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Stemedica Issued U.S. Patent For Ectodermal Stem Cells – Stem ... [Last Updated On: April 30th, 2013] [Originally Added On: April 30th, 2013]
- Clarifying the effect of stem cell therapy on cancer – Stem Cell Cafe [Last Updated On: May 2nd, 2013] [Originally Added On: May 2nd, 2013]